Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedLocation region label updated from Rhone-Alpes to Auvergne-Rhône-Alpes; Pierre-Bénite, Rhone-Alpes, France, 69495 is replaced with Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495.SummaryDifference0.1%

- Check28 days agoChange DetectedUpdated the page to show revision v3.2.0 and removed v3.0.2. This indicates a software/version update indicator on the page.SummaryDifference0.0%

- Check29 days agoChange DetectedUpgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed; this is a minor update with no substantive content changes.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing several previously listed locations. Notably, the core content related to the publications and research findings has been expanded.SummaryDifference34%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.